| 1 | CDH13
|
| Conditional deletion of Cadherin 13 perturbs Golgi cells and disrupts social and cognitive behaviors.
|
| Tantra M, Guo L, Kim J, Zainolabidin N, Eulenburg V, Augustine GJ, Chen AI.
|
| Genes Brain Behav 17(6):e12466. doi: 10.1111/gbb.12466. Epub 2018 Mar 15.
2018
|
| 2 | CDH13
|
| The association of six single nucleotide polymorphisms and their haplotypes in CDH13 with T2DM in a Han Chinese population.
|
| Li Y, Li C, Yang Y, Shi L, Tao W, Liu S, Yang M, Li X, Yao Y, Xiao C.
|
| Medicine (Baltimore) 96(22):e7063. doi: 10.1097/MD.0000000000007063.
2017
|
| 3 | CDH13
|
| T-cadherin promotes autophagy and survival in vascular smooth muscle cells through MEK1/2/Erk1/2 axis activation.
|
| Kyriakakis E, Frismantiene A, Dasen B, Pfaff D, Rivero O, Lesch KP, Erne P, Resink TJ, Philippova M.
|
| Cell Signal 35:163-175. doi: 10.1016/j.cellsig.2017.04.004. Epub 2017 Apr 6.
2017
|
| 4 | CDH13
|
| Protective role of Cadherin 13 in interneuron development.
|
| Killen AC, Barber M, Paulin JJW, Ranscht B, Parnavelas JG, Andrews WD.
|
| Brain Struct Funct 222(8):3567-3585. doi: 10.1007/s00429-017-1418-y. Epub 2017 Apr 6.
2017
|
| 5 | ADIPOQ, CDH13
|
| The unique prodomain of T-cadherin plays a key role in adiponectin binding with the essential extracellular cadherin repeats 1 and 2.
|
| Fukuda S, Kita S, Obata Y, Fujishima Y, Nagao H, Masuda S, Tanaka Y, Nishizawa H, Funahashi T, Takagi J, Maeda N, Shimomura I.
|
| J Biol Chem 292(19):7840-7849. doi: 10.1074/jbc.M117.780734. Epub 2017 Mar 21.
2017
|
| 6 | ADIPOQ, CDH13
|
| Adiponectin association with T-cadherin protects against neointima proliferation and atherosclerosis.
|
| Fujishima Y, Maeda N, Matsuda K, Masuda S, Mori T, Fukuda S, Sekimoto R, Yamaoka M, Obata Y, Kita S, Nishizawa H, Funahashi T, Ranscht B, Shimomura I.
|
| FASEB J 31(4):1571-1583. doi: 10.1096/fj.201601064R. Epub 2017 Jan 6.
2017
|
| 7 | CDH13
|
| Cadherin-13, a risk gene for ADHD and comorbid disorders, impacts GABAergic function in hippocampus and cognition.
|
| Rivero O, Selten MM, Sich S, Popp S, Bacmeister L, Amendola E, Negwer M, Schubert D, Proft F, Kiser D, Schmitt AG, Gross C, Kolk SM, Strekalova T, van den Hove D, Resink TJ, Nadif Kasri N, Lesch KP.
|
| Transl Psychiatry 5:e655. doi: 10.1038/tp.2015.152.
2015
|
| 8 | ANK2, ARSG, CDH13, DCLK1, GRM8, RIMBP2, SLC16A6
|
| Expression and replication studies to identify new candidate genes involved in normal hearing function.
|
| Girotto G, Vuckovic D, Buniello A, Lorente-Cánovas B, Lewis M, Gasparini P, Steel KP.
|
| PLoS One 9(1):e85352. doi: 10.1371/journal.pone.0085352. eCollection 2014. Erratum in: PLoS One. 2014;9(3):e91446.
2014
|
| 9 | CDH13
|
| The role of T-cadherin in axonal pathway formation in neocortical circuits.
|
| Hayano Y, Zhao H, Kobayashi H, Takeuchi K, Norioka S, Yamamoto N.
|
| Development 141(24):4784-93. doi: 10.1242/dev.108290.
2014
|
| 10 | CDH13
|
| Novel mechanism regulating endothelial permeability via T-cadherin-dependent VE-cadherin phosphorylation and clathrin-mediated endocytosis.
|
| Semina EV, Rubina KA, Sysoeva VY, Rutkevich PN, Kashirina NM, Tkachuk VA.
|
| Mol Cell Biochem 387(1-2):39-53. doi: 10.1007/s11010-013-1867-4. Epub 2013 Oct 18.
2014
|
| 11 | CDH13
|
| T-cadherin is essential for adiponectin-mediated revascularization.
|
| Parker-Duffen JL, Nakamura K, Silver M, Kikuchi R, Tigges U, Yoshida S, Denzel MS, Ranscht B, Walsh K.
|
| J Biol Chem 288(34):24886-97. doi: 10.1074/jbc.M113.454835. Epub 2013 Jul 3.
2013
|
| 12 | CDH13
|
| Cross-talk between EGFR and T-cadherin: EGFR activation promotes T-cadherin localization to intercellular contacts.
|
| Kyriakakis E, Maslova K, Frachet A, Ferri N, Contini A, Pfaff D, Erne P, Resink TJ, Philippova M.
|
| Cell Signal 25(5):1044-53. doi: 10.1016/j.cellsig.2013.02.001. Epub 2013 Feb 11.
2013
|
| 13 | CDH13
|
| T-cadherin attenuates insulin-dependent signalling, eNOS activation, and angiogenesis in vascular endothelial cells.
|
| Philippova M, Joshi MB, Pfaff D, Kyriakakis E, Maslova K, Erne P, Resink TJ.
|
| Cardiovasc Res 93(3):498-507. doi: 10.1093/cvr/cvs004. Epub 2012 Jan 10.
2012
|
| 14 | CDH13
|
| T-cadherin (Cdh13) in association with pancreatic β-cell granules contributes to second phase insulin secretion.
|
| Tyrberg B, Miles P, Azizian KT, Denzel MS, Nieves ML, Monosov EZ, Levine F, Ranscht B.
|
| Islets 3(6):327-37. doi: 10.4161/isl.3.6.17705. Epub 2011 Nov 1.
2011
|
| 15 | CDH13
|
| T-cadherin structures reveal a novel adhesive binding mechanism.
|
| Ciatto C, Bahna F, Zampieri N, VanSteenhouse HC, Katsamba PS, Ahlsen G, Harrison OJ, Brasch J, Jin X, Posy S, Vendome J, Ranscht B, Jessell TM, Honig B, Shapiro L.
|
| Nat Struct Mol Biol 17(3):339-47. Epub 2010 Feb 28.
2010
|
| 16 | CDH13, ZEB1
|
| Zeb1-mediated T-cadherin repression increases the invasive potential of gallbladder cancer.
|
| Adachi Y, Takeuchi T, Nagayama T, Ohtsuki Y, Furihata M.
|
| FEBS Lett 583(2):430-6. Epub 2008 Dec 29.
2009
|
| 17 | CDH13, CDH1, RARB, BVES, KCNH5, MGMT
|
| DNA methylation in tumor and matched normal tissues from non-small cell lung cancer patients.
|
| Feng Q, Hawes SE, Stern JE, Wiens L, Lu H, Dong ZM, Jordan CD, Kiviat NB, Vesselle H.
|
| Cancer Epidemiol Biomarkers Prev 17(3):645-54. 2008
|
| 18 | CDH13
|
| Promoter hypermethylation of CDH13 is a common, early event in human esophageal adenocarcinogenesis and correlates with clinical risk factors.
|
| Jin Z, Cheng Y, Olaru A, Kan T, Yang J, Paun B, Ito T, Hamilton JP, David S, Agarwal R, Selaru FM, Sato F, Abraham JM, Beer DG, Mori Y, Shimada Y, Meltzer SJ.
|
| Int J Cancer 123(10):2331-6.
2008
|
| 19 | CDH13, ITGB1
|
| T-cadherin enhances cell-matrix adhesiveness by regulating beta1 integrin trafficking in cutaneous squamous carcinoma cells.
|
| Mukoyama Y, Utani A, Matsui S, Zhou S, Miyachi Y, Matsuyoshi N.
|
| Genes Cells 12(6):787-96.
2007
|
| 20 | CDH13
|
| Regulation of T-cadherin by hormones, glucocorticoid and EGF.
|
| Bromhead C, Miller JH, McDonald FJ.
|
| Gene 374:58-67. Epub 2006 Mar 3. 2006
|
| 21 | CDH13
|
| T-cadherin protects endothelial cells from oxidative stress-induced apoptosis.
|
| Joshi MB, Philippova M, Ivanov D, Allenspach R, Erne P, Resink TJ.
|
| FASEB J. 19(12):1737-9. Epub 2005 Aug 12. 2005
|
| 22 | CDH13
|
| Prevalent hyper-methylation of the CDH13 gene promoter in malignant B cell lymphomas.
|
| Ogama Y, Ouchida M, Yoshino T, Ito S, Takimoto H, Shiote Y, Ishimaru F, Harada M, Tanimoto M, Shimizu K.
|
| Int J Oncol 25(3):685-91. 2004
|
| 23 | CDH13
|
| Aberrant methylation of the CDH13 (H-cadherin) promoter region in colorectal cancers and adenomas.
|
| Toyooka S, Toyooka KO, Harada K, Miyajima K, Makarla P, Sathyanarayana UG, Yin J, Sato F, Shivapurkar N, Meltzer SJ, Gazdar AF.
|
| Cancer Res 62(12):3382-6. 2002
|
| 24 | CDH13, NF1
|
| Heterozygosity for the neurofibromatosis 1 (NF1) tumor suppressor results in abnormalities in cell attachment, spreading and motility in astrocytes.
|
| Gutmann DH, Wu YL, Hedrick NM, Zhu Y, Guha A, Parada LF.
|
| Hum Mol Genet 10(26):3009-16. 2001
|
| 25 | CDH13
|
| Loss of expression and aberrant methylation of the CDH13 (H-cadherin) gene in breast and lung carcinomas.
|
| Toyooka KO, Toyooka S, Virmani AK, Sathyanarayana UG, Euhus DM, Gilcrease M, Minna JD, Gazdar AF.
|
| Cancer Res 61(11):4556-60. 2001
|
| 26 | CDH1, CDH10, CDH11, CDH12, CDH12P, CDH13, CDH15, CDH16, CDH17, CDH18, CDH19, CDH2, CDH20, CDH23, CDH3, CDH4, CDH5, CDH6, CDH7, CDH8, CDH9, PCDH11Y, PCDHA@, PCDHA1, PCDHA10, PCDHA11, PCDHA12, PCDHA13, PCDHA14, PCDHA2, PCDHA3, PCDHA4, PCDHA5, PCDHA6, PCDHA7, PCDHA8, PCDHA9, PCDHACT, PCDHB1, PCDHB10, PCDHB11, PCDHB12, PCDHB13, PCDHB14, PCDHB15, PCDHB16, PCDHB2, PCDHB3, PCDHB4, PCDHB5, PCDHB6, PCDHB7, PCDHB8, PCDHB9, PCDHAC1, PCDHAC2, PCDHGA1, PCDHGA10, PCDHGA11, PCDHGA12, PCDHGA2, PCDHGA3, PCDHGA4, PCDHGA5, PCDHGA6, PCDHGA7, PCDHGA8, PCDHGA9, PCDHGB1, PCDHGB2, PCDHGB3, PCDHGB4, PCDHGB5, PCDHGB6, PCDHGB7, PCDHGC3, PCDHGC4, PCDHGC5, PCDHGCT
|
| Phylogenetic analysis of the cadherin superfamily allows identification of six major subfamilies besides several solitary members.
|
| Nollet F, Kools P, van Roy F.
|
| J Mol Biol 299(3):551-72. Review. 2000
|
| 27 | CDH13, TSG16A, TSG16C
|
| Involvement of H-cadherin (CDH13) on 16q in the region of frequent deletion in ovarian cancer.
|
| Kawakami M, Staub J, Cliby W, Hartmann L, Smith DI, Shridhar V.
|
| Int J Oncol 15(4):715-20 1999
|
| 28 | CDH3, CDH5, CDH6, CDH7, CDH8, CDH11, CDH13, CDH15, CDH17
|
| Localization of human cadherin genes to chromosome regions exhibiting cancer-related loss of heterozygosity.
|
| Kremmidiotis G, et al.
|
| Genomics 49 : 467-471. 1998
|
| 29 | CDH13, TSG16H
|
| The H-cadherin (CDH13) gene is inactivated in human lung cancer.
|
| Sato M, et al.
|
| Hum Genet 103 : 96-101. 1998
|
| 30 | CDH1, CDH13
|
| H-cadherin, a novel cadherin with growth inhibitory functions and diminished expression in human breast cancer.
|
| Lee SW.
|
| Nat Med 2 : 776-782. 1996
|